Mortality Among Referral Patients With Hypertrophic Cardiomyopathy vs the General European Population

Authors:

Abstract
Hypertrophic cardiomyopathy (HCM) is a common genetic heart disease with a population prevalence ratio of approximately 1:500.1 Early HCM cohort studies reported a high mortality due to sudden cardiac death (SCD) and heart failure but were limited by a significant selection bias.2 Contemporary survival studies have shown that the prognosis for most individuals with the disease may be better than described previously, particularly when it is managed in line with current clinical practice guidelines,3 but the excess mortality that HCM conveys when compared with the general population remains unclear.4,5 We sought to compare the survival of patients with HCM in a large multicenter European cohort with that observed in the general population using contemporaneous country, age-stratified, and sex-stratified European mortality data.